{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:55:54Z","timestamp":1780048554391,"version":"3.53.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,16]],"date-time":"2015-11-16T00:00:00Z","timestamp":1447632000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1924-3","type":"journal-article","created":{"date-parts":[[2015,11,16]],"date-time":"2015-11-16T09:06:23Z","timestamp":1447664783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44\u03bd is an indicator for recurrence in advanced cancer"],"prefix":"10.1186","volume":"15","author":[{"given":"Cheng-Lin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Jui","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta-Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kung-Chao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ping","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Shen","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Derg","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,16]]},"reference":[{"key":"1924_CR1","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1245\/s10434-008-9886-1","volume":"15","author":"JB O\u2019Connell","year":"2008","unstructured":"O\u2019Connell JB, Maggard MA, Manunga J, Tomlinson JS, Reber HA, Ko CY, et al. Survival after resection of ampullary carcinoma: a national population-based study. Ann Surg Oncol. 2008;15:1820\u20137.","journal-title":"Ann Surg Oncol"},{"key":"1924_CR2","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/jso.21374","volume":"100","author":"J Albores-Saavedra","year":"2009","unstructured":"Albores-Saavedra J, Schwartz AM, Batich K, Henson DE. Cancers of the ampulla of Vater: demographics, morphology, and survival based on 5,625 cases from the seer program. J Surg Oncol. 2009;100:598\u2013605.","journal-title":"J Surg Oncol"},{"key":"1924_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1245\/s10434-006-9136-3","volume":"14","author":"HP Hsu","year":"2007","unstructured":"Hsu HP, Yang TM, Hsieh YH, Shan YS, Lin PW. Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer. Ann Surg Oncol. 2007;14:50\u201360.","journal-title":"Ann Surg Oncol"},{"key":"1924_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jamcollsurg.2008.01.028","volume":"207","author":"JT Carter","year":"2008","unstructured":"Carter JT, Grenert JP, Rubenstein L, Stewart L, Way LW. Tumors of the ampulla of Vater: histopathologic classification and predictors of survival. J Am Coll Surg. 2008;207:210\u20138.","journal-title":"J Am Coll Surg"},{"key":"1924_CR5","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1245\/s10434-011-2117-1","volume":"19","author":"M Palta","year":"2012","unstructured":"Palta M, Patel P, Broadwater G, Willett C, Pepek J, Tyler D, et al. Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy. Ann Surg Oncol. 2012;19:1535\u201340.","journal-title":"Ann Surg Oncol"},{"key":"1924_CR6","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0929-6646(09)60292-8","volume":"106","author":"HP Hsu","year":"2007","unstructured":"Hsu HP, Shan YS, Hsieh YH, Yang TM, Lin PW. Predictors of recurrence after pancreaticoduodenectomy in ampullary cancer: comparison between non-, early and later recurrence. J Formos Med Assoc. 2007;106:432\u201343.","journal-title":"J Formos Med Assoc"},{"key":"1924_CR7","first-page":"719","volume":"94","author":"JC Lee","year":"1995","unstructured":"Lee JC, Lin PW, Lin YJ, Lai J, Yang HB, Lai MD. Analysis of K-ras gene mutations in periampullary cancers, gallbladder cancers and cholangiocarcinomas from paraffin-embedded tissue sections. J Formos Med Assoc. 1995;94:719\u201323.","journal-title":"J Formos Med Assoc"},{"key":"1924_CR8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/jso.21493","volume":"101","author":"HP Hsu","year":"2010","unstructured":"Hsu HP, Shan YS, Jin YT, Lai MD, Lin PW. Loss of E-cadherin and \u03b2-catenin is correlated with poor prognosis of ampullary neoplasms. J Surg Oncol. 2010;101:356\u201362.","journal-title":"J Surg Oncol"},{"key":"1924_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4161\/cbt.10.2.12160","volume":"10","author":"HP Hsu","year":"2010","unstructured":"Hsu HP, Shan YS, Lai MD, Lin PW. Osteopontin-positive infiltrating tumor-associated macrophages in bulky ampullary cancer predict survival. Cancer Biol Ther. 2010;10:144\u201354.","journal-title":"Cancer Biol Ther"},{"key":"1924_CR10","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00535-011-0442-6","volume":"46","author":"DL Dewi","year":"2011","unstructured":"Dewi DL, Ishii H, Kano Y, Nishikawa S, Haraguchi N, Sakai D, et al. Cancer stem cell theory in gastrointestinal malignancies: recent progress and upcoming challenges. J Gastroenterol. 2011;46:1145\u201357.","journal-title":"J Gastroenterol"},{"key":"1924_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.canlet.2012.04.016","volume":"338","author":"N Ashley","year":"2013","unstructured":"Ashley N. Regulation of intestinal cancer stem cells. Cancer Lett. 2013;338:120\u20136.","journal-title":"Cancer Lett"},{"key":"1924_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/modpathol.2008.192","volume":"22","author":"D Baumhoer","year":"2009","unstructured":"Baumhoer D, Riener MO, Zlobec I, Tornillo L, Vogetseder A, Kristiansen G, et al. Expression of CD24, P-cadherin and S100A4 in tumors of the ampulla of Vater. Mod Pathol. 2009;22:306\u201313.","journal-title":"Mod Pathol"},{"key":"1924_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/jclinpath-2011-200043","volume":"65","author":"S Piscuoglio","year":"2012","unstructured":"Piscuoglio S, Lehmann FS, Zlobec I, Tornillo L, Dietmaier W, Hartmann A, et al. Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater. J Clin Pathol. 2012;65:140\u20135.","journal-title":"J Clin Pathol"},{"key":"1924_CR14","first-page":"211","volume":"41","author":"SH Cho","year":"2012","unstructured":"Cho SH, Park YS, Kim HJ, Kim CH, Lim SW, Huh JW, et al. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion. Int J Oncol. 2012;41:211\u20138.","journal-title":"Int J Oncol"},{"key":"1924_CR15","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1096\/fj.12-203786","volume":"26","author":"MR Dallas","year":"2012","unstructured":"Dallas MR, Liu G, Chen WC, Thomas SN, Wirtz D, Huso DL, et al. Divergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis. FASEB J. 2012;26:2648\u201356.","journal-title":"FASEB J"},{"key":"1924_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1749-6632.2000.tb06704.x","volume":"910","author":"P Herrlich","year":"2000","unstructured":"Herrlich P, Morrison H, Sleeman J, Orian-Rousseau V, K\u00f6nig H, Weg-Remers S, et al. CD44 acts both as a growth- and invasiveness-promoting molecule and as a tumor-suppressing cofactor. Ann N Y Acad Sci. 2000;910:106\u201320.","journal-title":"Ann N Y Acad Sci"},{"key":"1924_CR17","first-page":"4539","volume":"54","author":"SB Fox","year":"1994","unstructured":"Fox SB, Fawcett J, Jackson DG, Collins I, Gatter KC, Harris AL, et al. Normal human tissue, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res. 1994;54:4539\u201346.","journal-title":"Cancer Res"},{"key":"1924_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nrc3023","volume":"11","author":"M Z\u00f6ller","year":"2011","unstructured":"Z\u00f6ller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer. 2011;11:254\u201367.","journal-title":"Nat Rev Cancer"},{"key":"1924_CR19","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3892\/or.2013.2273","volume":"29","author":"S Saito","year":"2013","unstructured":"Saito S, Okabe H, Watanabe M, Ishimoto T, Iwatsuki M, Baba Y, et al. CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer. Oncol Rep. 2013;29:1570\u20138.","journal-title":"Oncol Rep"},{"key":"1924_CR20","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/labinvest.3700112","volume":"84","author":"AL Omara-Opyene","year":"2004","unstructured":"Omara-Opyene AL, Qiu J, Shah GV, Iczkowski KA. Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18. Lab Invest. 2004;84:894\u2013907.","journal-title":"Lab Invest"},{"key":"1924_CR21","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1691::AID-CNCR10>3.0.CO;2-Z","volume":"86","author":"Y Yokoyama","year":"1999","unstructured":"Yokoyama Y, Hiyama E, Murakami Y, Matsuura Y, Yokoyama T. Lack of CD44 variant 6 expression in advanced extrahepatic bile duct\/ampullary carcinoma. Cancer. 1999;86:1691\u20139.","journal-title":"Cancer"},{"key":"1924_CR22","first-page":"87","volume-title":"International agency for research on cancer","author":"FT Bosman","year":"2010","unstructured":"Bosman FT, Carneiro F, Hruban RH, Theise ND, WHO Classification of Tumours of the Digestive System. Invasive adenocarcinoma of the ampullary region. In: Albores Saavedra J, Hruban RH, Klimstra DS, Zamboni G, editors. International agency for research on cancer. Lyon: WHO Publications Centre; 2010. p. 87\u201391."},{"key":"1924_CR23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1101\/gr.3.2.100","volume":"3","author":"DH Weering Van","year":"1993","unstructured":"Van Weering DH, Baas PD, Bos JL. A PCR-based method for the analysis of human CD44 splice products. PCR Methods Appl. 1993;3:100\u20136.","journal-title":"PCR Methods Appl"},{"key":"1924_CR24","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1245\/s10434-010-0927-1","volume":"17","author":"KH Hsu","year":"2010","unstructured":"Hsu KH, Tsai HW, Lin PW, Hsu YS, Shan YS, Lu PJ. Clinical implication and mitotic effect of CD44 cleavage in relation to osteopontin\/CD44 interaction and dysregulated cell cycle protein in gastrointestinal stromal tumor. Ann Surg Oncol. 2010;17:2199\u2013212.","journal-title":"Ann Surg Oncol"},{"issue":"16","key":"1924_CR25","first-page":"e1","volume":"10","author":"K Yang","year":"2010","unstructured":"Yang K, Tang Y, Habermehl GK, Iczkowski KA. Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity. BMC Cancer. 2010;10(16):e1\u2013e12.","journal-title":"BMC Cancer"},{"key":"1924_CR26","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/sj.onc.1209849","volume":"26","author":"Y Bai","year":"2007","unstructured":"Bai Y, Liu YJ, Wang H, Xu Y, Stamenkovic I, Yu Q. Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin. Oncogene. 2007;26:836\u201350.","journal-title":"Oncogene"},{"key":"1924_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12015-007-0006-6","volume":"3","author":"M Katoh","year":"2007","unstructured":"Katoh M. Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis. Stem Cell Rev. 2007;3:30\u20138.","journal-title":"Stem Cell Rev"},{"key":"1924_CR28","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.yexcr.2013.04.017","volume":"319","author":"A Descot","year":"2013","unstructured":"Descot A, Oskarsson T. The molecular composition of the metastatic niche. Exp Cell Res. 2013;319:1679\u201386.","journal-title":"Exp Cell Res"},{"key":"1924_CR29","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2015.2222","author":"L Li","year":"2015","unstructured":"Li L, Qi L, Liang Z, Song W, Liu Y, Wang Y, et al. Transforming growth factor-\u03b21 induces EMT by the transactivation of epidermal growth factor signaling through HA\/CD44 in lung and breast cancer cells. Int J Mol Med. 2015. doi: 10.3892\/ijmm.2015.2222 .","journal-title":"Int J Mol Med"},{"key":"1924_CR30","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/1471-2407-8-260","volume":"8","author":"EW Robbins","year":"2008","unstructured":"Robbins EW, Travanty EA, Yang K, Iczkowski KA. MAP kinase pathways and calcitonin influence CD44 alternate isoform expression in prostate cancer cells. BMC Cancer. 2008;8:260. e1-e9.","journal-title":"BMC Cancer"},{"key":"1924_CR31","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.bbrc.2013.12.016","volume":"443","author":"GJ Yoshida","year":"2014","unstructured":"Yoshida GJ, Saya H. Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation. Biochem Biophys Res Commun. 2014;443:622\u20137.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1924-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1924-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1924-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T11:48:49Z","timestamp":1599824929000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1924-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,16]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1924"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1924-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,16]]},"article-number":"903"}}